TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 278 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q2 2022. The put-call ratio across all filers is 0.15 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $430,000 | -12.4% | 30 | 0.0% | 0.00% | – |
Q3 2021 | $491,000 | -2.4% | 30 | 0.0% | 0.00% | – |
Q2 2021 | $503,000 | -8.2% | 30 | 0.0% | 0.00% | – |
Q1 2021 | $548,000 | +0.4% | 30 | 0.0% | 0.00% | – |
Q4 2020 | $546,000 | +2.1% | 30 | 0.0% | 0.00% | – |
Q3 2020 | $535,000 | -0.6% | 30 | 0.0% | 0.00% | – |
Q2 2020 | $538,000 | +18.2% | 30 | 0.0% | 0.00% | – |
Q1 2020 | $455,000 | -24.2% | 30 | 0.0% | 0.00% | – |
Q4 2019 | $600,000 | +16.3% | 30 | 0.0% | 0.00% | – |
Q3 2019 | $516,000 | -2.8% | 30 | 0.0% | 0.00% | – |
Q2 2019 | $531,000 | -13.1% | 30 | 0.0% | 0.00% | – |
Q1 2019 | $611,000 | – | 30 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bartlett & Co. LLC | 20,781 | $296 | 0.01% |
Valued Wealth Advisors LLC | 231 | $3,574 | 0.00% |
BALDWIN BROTHERS LLC/MA | 2,035 | $29,039 | 0.00% |